A clinician's guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ...

Area of Science:

• Endocrinology
• Molecular Genetics
• Medical Diagnostics

Background:

• Two genes encode major thyroid hormone receptor (TR) isoforms, TRβ and TRα.
• Mutations in these genes lead to Resistance to Thyroid Hormone (RTH) syndromes, specifically RTHβ and RTHα.
• Phenotypes of RTH can vary significantly due to mutations within the same receptor isoform and between different isoforms.

Purpose of the Study:

• To provide a clinical guide for the diagnosis and treatment of RTHβ and RTHα.
• To elucidate the role of tissue-specific distribution of TRβ and TRα in RTH presentation.
• To highlight diagnostic challenges and key biochemical markers for RTH.

Main Methods:

• Review of genetic basis of RTH.
• Analysis of clinical phenotypes associated with TR gene mutations.
• Correlation of laboratory findings (serum fT4, TSH, fT4/T3 ratio) with RTH diagnosis.

Main Results:

• RTH diagnosis should be considered in patients with unexplained elevated free T4 (fT4) and unsuppressed TSH.
• A decreased serum free T4/T3 ratio is a key indicator for RTH.
• Tissue-specific distribution of TR isoforms influences the manifestation of RTH.

Conclusions:

• Accurate diagnosis of RTH requires consideration of clinical presentation and specific laboratory findings.
• Understanding isoform-specific roles of TRβ and TRα is crucial for managing RTH.
• This guide aims to improve clinical management of RTH syndromes.